# OnCo record cp-383 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cp-383/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cp-383" ;
  schema:name "CP-383"@en ;
  schema:description "CP-383 is an experimental small molecule from Tasca Therapeutics, in phase 1 trials for colorectal cancer, small cell lung cancer and head and neck squamous cell carcinoma and other cancers."@en ;
  schema:url <https://onco.cc/drugs/cp-383/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.tascatx.com/pipeline>, <https://www.tascatx.com/pipeline>, <https://clinicaltrials.gov/api/v2/studies/NCT07030257>, <https://clinicaltrials.gov/search?intr=CP-383> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/nsclc/> ;
  onco:companies <https://onco.cc/companies/tasca-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07030257/> .